Blog
-
Retatrutide Research Context: Reading a Three-Receptor Literature
Retatrutide is described in published research as a peptide evaluated for activity at GIP, GLP-1, and glucagon receptors. “Three-receptor” or “triple agonist” is therefore a literature shorthand for a reported target panel. It is not proof of the ide -
Semaglutide Research Records: Receptor Terminology, Identity, and Lot Documentation
Semaglutide is discussed in scientific literature as a GLP-1 receptor agonist, but that label does not identify a particular study material, product lot, model, or outcome. A usable research record connects four things: the source’s stated compound i
